Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
US5990109A · kind A · utility
97Cited by
14References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 1999 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Mar 4, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel heterocyclo-substituted imidazopyrazines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.